Career history of Peter J. Azzarello
Former positions of Peter J. Azzarello
Companies | Position | Start | End |
---|---|---|---|
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Comptroller/Controller/Auditor | 2013-11-27 | 2016-07-10 |
Corporate Officer/Principal | 2013-03-30 | 2013-11-27 | |
Corporate Secretary | 2013-03-30 | 2016-07-10 | |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Director of Finance/CFO | 2004-10-31 | 2012-09-29 |
NetBank, Inc.
NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Corporate Officer/Principal | 2000-12-31 | 2002-12-31 |
Anaconda Pharma SASU
Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Chief Executive Officer | - | - |
Training of Peter J. Azzarello
Florida Atlantic University | Undergraduate Degree |
Statistics
International
United States | 5 |
France | 2 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Comptroller/Controller/Auditor | 1 |
Sectoral
Health Technology | 4 |
Finance | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
NetBank, Inc.
NetBank, Inc. Major BanksFinance NetBank, Inc. provides on-line retail banking and mortgage lending services. It operates in two segments: Retail banking and Mortgage lending. Retail banking provides consumer banking products like checking, money market and certificates of deposit, as well as, online bill payment and presentment, eStatements, wireless account access, account consolidation and securities brokerage services. Mortgage lending provides mortgage loans and related services. The company is headquartered in Alpharetta, GA. | Finance |
Inhibitex LLC
Inhibitex LLC Pharmaceuticals: MajorHealth Technology Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA. | Health Technology |
Anaconda Pharma SASU
Anaconda Pharma SASU BiotechnologyHealth Technology Anaconda Pharma SAS provides biotechnology services. It offers biotechnology services and develops treatments against infections by human papillomavirus. The company was founded in 2003 and is headquartered in Villejuif, France. | Health Technology |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |
- Stock Market
- Insiders
- Peter J. Azzarello
- Experience